<DOC>
	<DOCNO>NCT01428362</DOCNO>
	<brief_summary>The purpose study determine whether VI-1121 safe , well tolerate , effective daily treatment Alzheimer 's disease worsen despite current treatment .</brief_summary>
	<brief_title>VI-1121 Treatment Alzheimer 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>clinical diagnosis Alzheimer 's disease CT MRI within 2 year prior study stable dose current Alzheimer 's treatment least 3 month advance , severe , progressive unstable disease history cerebrovascular disease myocardial infarction within 6 month</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>donepezil</keyword>
	<keyword>VI-1121</keyword>
</DOC>